Sign Out
CANCIDAS is indicated in adult and pediatric patients (12 months and older) for: Empirical therapy for presumed fungal infections (such as Candida or Aspergillus) in febrile, neutropenic patients, whose fever has failed to respond to broad-spectrum antibiotics.
Treatment of Candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. CANCIDAS has not been studied in endocarditis, osteomyelitis, and meningitis due to Candida.
Treatment of Esophageal Candidiasis.
Treatment of Invasive Aspergillosis in patients who are refractory to or intolerant of other therapies.
